Patel Ronil A. 4
4 · Ocuphire Pharma, Inc. · Filed Dec 5, 2023
Insider Transaction Report
Form 4
Patel Ronil A.
Chief Business Officer
Transactions
- Award
Common Stock
2023-12-01+49,692→ 91,996 total - Award
Employee Stock Option (right to buy)
2023-12-01+74,538→ 74,538 totalExercise: $2.99Exp: 2033-11-30→ Common Stock (74,538 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest with respect to 25% on the six month anniversary of the grant date, with the remaining shares vesting in equal installments every six months thereafter over the two years following the grant date, subject to continuing service.
- [F2]The option will vest with respect to 25% on the six month anniversary of the grant date, with the remaining shares vesting in equal installments every six months thereafter over the two years following the grant date, subject to continuing service.